Multiple Sclerosis Drug Market Growth Trajectory by 2034
The Multiple Sclerosis Drug Market is expected to increase at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2034, from its 2024 valuation of USD 27.8 billion to USD 48.5 billion by the end of 2034. This steady growth reflects continued investment in research, the rising prevalence of MS worldwide, and an expanding treatment portfolio ranging from disease-modifying therapies (DMTs) to next-generation biologics. Multiple Sclerosis Drug Industry Demand The Multiple Sclerosis (MS) Drug Market encompasses a wide range of pharmaceutical treatments aimed at managing the symptoms and progression of MS—an autoimmune disorder that disrupts communication between the brain and the rest of the body. The medications are intended to either control flare-ups, reduce symptoms, or limit the progression of the disease. Several factors are contributing to the growing demand for MS drugs: · Cost-effectiveness : With ongoing innov...